Titre :
  • A study of the value of p53, HER2, and Bcl-2 in the prediction of response to doxorubicin and paclitaxel as single agents in metastatic breast cancer: a companion study to EORTC 10923.
Auteur : Hamilton, Andrew ; Larsimont, Denis ; Paridaens, Robert ; Drijkoningen, M ; Van de Vijver, Marc J ; Bruning, Peter ; Hanby, A ; Houston, S ; Treilleux, I ; Guastalla, Jean Paul ; Van Vreckem, A ; Sylvester, R. ; Piccart-Gebhart, Martine
Informations sur la publication : Clinical breast cancer, 1, 3, (page 233-40; discussion 241-2)
Statut de publication : Publié, 2000-10
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Antibiotics, Antineoplastic -- therapeutic use
Antineoplastic Agents, Phytogenic -- therapeutic use
Breast Neoplasms -- drug therapy
Breast Neoplasms -- metabolism
Breast Neoplasms -- pathology
Doxorubicin -- therapeutic use
Immunoenzyme Techniques
Middle Aged
Paclitaxel -- therapeutic use
Prospective Studies
Proto-Oncogene Proteins c-bcl-2 -- metabolism
Receptor, erbB-2 -- metabolism
Tumor Suppressor Protein p53 -- metabolism
Note : Clinical Trial
Clinical Trial, Phase III
Comparative Study
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue :
  • Anglais
Identificateurs : urn:issn:1526-8209